Clessidra Capital Credit SGR participates in a club deal to delist Health Italia from Euronext Growth Milan, aiming to enhance its integrated healthcare offerings and market position.

Information on the Target

Health Italia is a prominent player in the health and wellness sector in Italy, focusing on integrated healthcare services. The company is poised for a significant transformation as it prepares for a delisting from Euronext Growth Milan, which aims to enhance its operational framework and market offerings.

The upcoming deal will be facilitated by Clessidra Capital Credit SGR, a subsidiary of Clessidra Holding, alongside a private investor club led by experienced industry leaders Giovanni Giuliani and Stefano Pellegrino. The strategic initiative seeks to fortify Health Italia's position as a reference platform for integrated healthcare services.

Industry Overview

The healthcare sector in Italy is undergoing substantial evolution, driven by increasing demand for integrated healthcare services and well-being solutions.

View Source

Similar Deals

Silver Economy Fund Medical International Research (Mir)

2025

Buyout Medical Diagnostic & Testing Equipment Italy
Quadrivio Group MIR

2025

Buyout Medical Diagnostic & Testing Equipment Italy
Silver Economy Fund Mir-Medical International Research

2025

Buyout Medical Diagnostic & Testing Equipment Italy
Quadrivio Group Mir (Medical International Research)

2025

Buyout Medical Diagnostic & Testing Equipment Italy
Silver Economy Fund MIR – Medical International Research

2025

Buyout Medical Diagnostic & Testing Equipment Italy
Silver Economy Fund (Quadrivio) Biotec Italia

2025

Buyout Healthcare Facilities & Services (NEC) Italy

Clessidra Capital Credit

invested in

Health Italia

in 2025

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert